Respiratory Syncytial Virus (RSV) Infection
Symptoms, Doctors, Treatments, Advances & More

Respiratory Syncytial Virus (RSV) Infection Overview

Save information for later
Sign Up

Learn About Respiratory Syncytial Virus (RSV) Infection

What is the definition of Respiratory Syncytial Virus (RSV) Infection?
Respiratory syncytial virus (RSV) is a common virus that causes infections of the respiratory tract and lungs. Respiratory syncytial virus mostly affects children but can also infect adults.
What are the symptoms of Respiratory Syncytial Virus (RSV) Infection?
Symptoms of respiratory syncytial virus can be similar to a mild cold in older, healthy children and adults. In babies under 12 months, premature infants, individuals with heart or lung disease, immunocompromised individuals, older adults, and individuals with other serious medical problems, respiratory syncytial virus can cause severe infection. Symptoms of respiratory syncytial virus infection usually appear within 4-to-6 days after infection. Symptoms of respiratory syncytial virus infection include decreased appetite, runny nose, congestion, cough, sneezing, fever, sore throat, headache, and wheezing. Symptoms of severe respiratory syncytial virus infection may also include fever; severe cough; wheezing; short, shallow, and rapid breathing or difficulty breathing; bluish skin; poor appetite; extreme fatigue; and irritability.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Respiratory Syncytial Virus (RSV) Infection?
Treatment for respiratory syncytial virus infection is focused on supportive and self-care, including over-the-counter pain medications, such as acetaminophen; saline nasal drops; cough medicine; and fluids. (Note that children should never be given aspirin. In addition, children under four years of age should not be given cough medicine unless prescribed by a physician.) Antibiotics may be prescribed if bacterial pneumonia develops. Patients with severe respiratory syncytial virus infection are treated in the hospital. In-hospital treatment for patients with severe respiratory syncytial virus infection may include intravenous fluids, antibiotics, humidified oxygen, intubation, and mechanical ventilation.
Who are the top Respiratory Syncytial Virus (RSV) Infection Local Doctors?
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Ann Falsey
Infectious Disease
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Ann Falsey
Infectious Disease

Rochester General Hospital

1425 Portland Ave, 
Rochester, NY 
585-922-4003
Languages Spoken:
English
See accepted insurances

Ann Falsey is an Infectious Disease provider practicing medicine in Rochester, New York. Dr. Falsey is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Flu, and Severe Acute Respiratory Syndrome (SARS).

Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Octavio Ramilo
Infectious Disease
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Octavio Ramilo
Infectious Disease

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
614-722-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Octavio Ramilo is an Infectious Disease provider practicing medicine in Columbus, Ohio. Dr. Ramilo is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Infantile Neutropenia, and Kawasaki Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Respiratory Syncytial Virus (RSV) Infection
Louis J. Bont
Elite in Respiratory Syncytial Virus (RSV) Infection
Louis J. Bont
Utrecht, UT, NL 

Louis Bont practices practicing medicine in Utrecht, Netherlands. Mr. Bont is rated as an Elite expert by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Bronchitis, Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, and Stridor.

View All Doctors
What are the latest Respiratory Syncytial Virus (RSV) Infection Clinical Trials?
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Deurremidevir Hydrobromide for Oral Suspension in Infants and Young Children With Respiratory Syncytial Virus Infection
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Deurremidevir Hydrobromide for Oral Suspension in Infants and Young Children With Respiratory Syncytial Virus Infection
Enrollment Status: Recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: This is a randomized, double-blind, placebo-controlled, parallel-group trial conducted in infants and young children aged 1 to 36 months with RSV infection. A total of 498 subjects are expected to be enrolled and randomly assigned to the investigational product group or the placebo group in a 2:1 ratio; Administration will be based on the subject's weight, with a dose of 20 mg/kg three times daily...

Match to trials
Find the right clinical trials for you in under a minute
Get started
An Open-Label Study to Assess the Safety and Efficacy of Remdesivir for Treatment of Symptomatic Laboratory-Confirmed Respiratory Syncytial Virus Infection of the Upper Respiratory Tract in Patients Receiving Cellular or Bispecific Antibody Therapies
An Open-Label Study to Assess the Safety and Efficacy of Remdesivir for Treatment of Symptomatic Laboratory-Confirmed Respiratory Syncytial Virus Infection of the Upper Respiratory Tract in Patients Receiving Cellular or Bispecific Antibody Therapies
Enrollment Status: Recruiting
Publish Date: February 27, 2026
Intervention Type: Other, Procedure, Drug
Study Phase: Phase 2

Summary: This phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune system, making infections more frequent and reducing the body's ability to fight the infections. RSV infections are one...

View All Clinical Trials